BACK, Kevin Richard,CRAM, Michael,HARPER, Aidan James,HUANG, W. James,LILLIS, Jonathan Richard,LUKAS, Timothy Michael,LUTHRA, Sumit
申请号：
SG11201703826T
公开号：
SG11201703826TA
申请日:
2015.12.10
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.
